| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 7.82M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 12X1.F returned -67.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -12.9% |
| 1 year | -67.8% |
| 5 years | -83.4% |
| 10 years | -5.0% |
| All-time high | €19.50 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 12X1.F would be worth today ›No. Anavex Life Sciences Corp. has not paid a dividend in the past 12 months.
Anavex Life Sciences Corp. is part of the Healthcare sector.
Anavex Life Sciences Corp. has a market cap of 236.28M EUR, based on the latest quote.
